6533b7dcfe1ef96bd1272a19

RESEARCH PRODUCT

Determinants of procalcitonin concentration in acute heart failure.

Juan SanchisArturo CarrataláEduardo NúñezMaria Pilar VillanuevaJulio NúñezAnna Mollar

subject

CalcitoninMalemedicine.medical_specialtyCalcitonin Gene-Related PeptideFibrinogenGastroenterologyProcalcitoninCohort Studieschemistry.chemical_compoundInternal medicineHeart ratemedicineHumansProtein PrecursorsHeart FailureCreatinineEjection fractionbusiness.industryMiddle Agedmedicine.diseasechemistryHeart failureAcute DiseaseUreaFemaleHemoglobinCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drug

description

Age, years 73.1 ± 10.4 Male, n (%) 133 (51.0) Hypertension, n (%) 212 (81.2) Diabetes mellitus, n (%) 126 (49.4) Previous smoker, n (%) 104 (28.2) Ischemic etiology, n (%) 92 (35.3) Peripheral oedema, n (%) 187 (71.7) Previous admission for AHF, n (%) 95 (36.4) Prior use of beta-blockers, n (%) 111 (42.5) Prior use of loop diuretics, n (%) 175 (67.0) Prior use of ACEI/ARB, n (%) 134 (51.3) Heart rate, beats/min 97 ± 28 SBP, mm Hg 148 ± 34 DBP, mm Hg 81 ± 19 Atrial fibrillation, n (%) 119 (45.6) Hemoglobin, g/dl 12.1 ± 2.0 Serum creatinine, mg/dl 1.23 ± 0.57 Urea, mg/dl 60.5 ± 30.1 Sodium, mEq/l 137.8 ± 4.7 NT-proBNP, pg/ml 4813 (6011) Leukocyte count, 10 cells/l 9286 ± 3468 Relative lymphocyte count, % 17.4 ± 10.4 Gamma glutamyl transpeptidase, U/l a 48 (55) TnTHs, pg/ml a 31.3 (39.5) CRP, mg/l 14.3 (24.9) Fibrinogen, g/l 5.1 ± 1.16 Procalcitonin, ng/ml a 0.06 (0.06) Endotoxin, EU/ml a 0.67 (0.46) IL-1b, pg/ml 0.12 (0.25) IL-6, pg/ml 16.8 (45.1) TNF-alfa, pg/ml 12.4 (20.6) Il-10, pg/ml 28.2 (93.8) Total cholesterol, mg/dl 156.8 ± 47.6 LDL, mg/dl 100.8 ± 36.2 HDL, mg/dl 43.9 ± 13.6 LVEF, % 49.3 ± 15.8

yearjournalcountryeditionlanguage
2014-08-15International journal of cardiology
10.1016/j.ijcard.2014.08.106https://pubmed.ncbi.nlm.nih.gov/25194863